We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+7.48%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$19.3B
AUM Growth
+$1.53B
Cap. Flow
+$473M
Cap. Flow %
2.45%
Top 10 Hldgs %
16.98%
Holding
3,283
New
233
Increased
1,447
Reduced
1,348
Closed
182

Sector Composition

Rank Sector Weight
1 Technology 7.96%
2 Financials 4.93%
3 Healthcare 4.48%
4 Consumer Discretionary 3.58%
5 Consumer Staples 3.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLQT icon
3026
SelectQuote
SLQT
$124M
$25K ﹤0.01%
+36,792
New +$24.1K
GMDA
3027
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$25K ﹤0.01%
+19,075
New +$30.2K
AREC icon
3028
American Resources Corp
AREC
$300M
$24K ﹤0.01%
17,982
+50
+0.3% +$91
BNGO icon
3029
Bionano Genomics
BNGO
$13.8M
$23K ﹤0.01%
+27
New +$34K
DNN icon
3030
Denison Mines
DNN
$2.98B
$23K ﹤0.01%
+20,108
New +$23.8K
SBEV icon
3031
Splash Beverage Group
SBEV
$2.58M
$23K ﹤0.01%
152
WPRT
3032
Westport Fuel Systems
WPRT
$34.6M
$23K ﹤0.01%
2,956
-614
-17% -$5.26K
BTBT icon
3033
Bit Digital
BTBT
$509M
$22K ﹤0.01%
37,480
-204,624
-85% -$191K
GEVO icon
3034
Gevo
GEVO
$391M
$22K ﹤0.01%
11,748
-172
-1% -$363
VFF icon
3035
Village Farms International
VFF
$307M
$22K ﹤0.01%
16,374
-2,425
-13% -$4.61K
SPRU icon
3036
Spruce Power Holding Corp
SPRU
$38.9M
$21K ﹤0.01%
+2,905
New +$20.6K
BDTX icon
3037
Black Diamond Therapeutics
BDTX
$121M
$20K ﹤0.01%
11,231
CLSD
3038
DELISTED
Clearside Biomedical
CLSD
$20K ﹤0.01%
1,167
-566
-33% -$10.2K
OGI
3039
Organigram Holdings
OGI
$182M
$20K ﹤0.01%
6,136
+348
+6% +$1.31K
TSP
3040
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$20K ﹤0.01%
11,996
-1,766
-13% -$6.29K
AMRS
3041
DELISTED
Amyris Inc.
AMRS
$20K ﹤0.01%
13,021
SENS icon
3042
Senseonics Holdings Inc
SENS
$419M
$19K ﹤0.01%
906
-10
-1% -$231
SDC
3043
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$19K ﹤0.01%
52,833
-8,129
-13% -$5.36K
VORB
3044
DELISTED
Virgin Orbit Holdings, Inc. Common Stock
VORB
$19K ﹤0.01%
10,500
DHC
3045
Diversified Healthcare Trust
DHC
$2.02B
$18K ﹤0.01%
27,234
+127
+0.5% +$125
DTIL icon
3046
Precision BioSciences
DTIL
$205M
$18K ﹤0.01%
508
-33
-6% -$1.3K
UAMY icon
3047
United States Antimony
UAMY
$736M
$18K ﹤0.01%
37,050
+4,050
+12% +$1.57K
DMTK
3048
DELISTED
DermTech, Inc. Common Stock
DMTK
$18K ﹤0.01%
10,258
-3,102
-23% -$8.25K
VLDR
3049
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$18K ﹤0.01%
23,760
+2,699
+13% +$2.55K
TONX
3050
TON Strategy Co
TONX
$162M
$17K ﹤0.01%
13

Similar funds

Cambridge Investment Research Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Cambridge Investment Research Advisors held 3,283 positions worth $19.3B, up 8.6% from $17.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Cambridge Investment Research Advisors's Q4 2022 filing shows 233 new, 1,447 increased, 1,348 reduced and 182 closed positions. Its largest new stake was FS Credit Opportunities Corp: 3,326,855 shares worth $15.7M. The largest sale was Vanguard Short-Term Treasury ETF, an estimated $22.3M.

By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 8.9% a quarter earlier, followed by Financials and Healthcare.

  • Cambridge Investment Research Advisors's largest Q4 2022 buy was FS Credit Opportunities Corp: 3,326,855 shares worth $15.7M.
  • Cambridge Investment Research Advisors added most to iShares 0-3 Month Treasury Bond ETF in Q4 2022, an estimated $66.9M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2022 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $22.3M.
  • Cambridge Investment Research Advisors fully exited Invesco BulletShares 2022 Corporate Bond ETF in Q4 2022, selling an estimated $12.7M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 17% of its $19.3B portfolio in Q4 2022.
  • Cambridge Investment Research Advisors opened 233 new positions and closed 182 in Q4 2022.
  • Cambridge Investment Research Advisors's portfolio value rose 8.6% quarter-over-quarter to $19.3B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.